Additionally, the corresponding radiological supervision and interpretation code (74485) was revised to specify that the code applies only to the ureter(s) or urethra vs a nephrostomy tract
MariTide Name: Maridebart cafraglutide (MariTide, formerly AMG 133) Manufacturer: Amgen Current stage: US phase III trial currently underway (MARITIME, NCT06858839) Takeaway: The dual agonist/antagonist action of MariTide could promise higher weight loss with fewer side effects, with dosing at less frequent intervals but more studies are needed
Improved Formulations and Delivery Methods Other advancements include longer-acting formulations that may eventually require less frequent dosing, improved delivery methods that enhance comfort and convenience, and combination approaches that pair GLP-1 therapy with complementary treatments
According to a recently released study in Cell , intermittent fasting can be an underlying cause for hair loss
For more information, take a look at our What is Saxenda page